BCL2 and diffuse large B-cell lymphoma: DLBCLs co-expressing MYC and BCL2 (double-expressor lymphomas) also have a worse prognosis than other DLBCL-NOS (not otherwise specified), but their behavior is not as aggressive as that of DH/TH lymphomas8.